Your browser is no longer supported. Please, upgrade your browser.
ANIX Anixa Biosciences, Inc. monthly Stock Chart
Anixa Biosciences, Inc.
Index- P/E- EPS (ttm)-0.46 Insider Own5.40% Shs Outstand23.17M Perf Week3.96%
Market Cap56.36M Forward P/E- EPS next Y-0.51 Insider Trans15.79% Shs Float22.37M Perf Month45.23%
Income-9.90M PEG- EPS next Q-0.11 Inst Own7.70% Short Float3.99% Perf Quarter61.45%
Sales0.00M P/S- EPS this Y25.90% Inst Trans18.00% Short Ratio4.65 Perf Half Y45.23%
Book/sh0.37 P/B7.81 EPS next Y-8.50% ROA-142.50% Target Price- Perf Year-23.34%
Cash/sh0.46 P/C6.26 EPS next 5Y- ROE-160.80% 52W Range1.33 - 4.13 Perf YTD-11.89%
Dividend- P/FCF- EPS past 5Y11.80% ROI-228.70% 52W High-30.02% Beta1.41
Dividend %- Quick Ratio7.60 Sales past 5Y-41.60% Gross Margin- 52W Low117.29% ATR0.21
Employees7 Current Ratio7.60 Sales Q/Q- Oper. Margin- RSI (14)66.13 Volatility9.22% 9.08%
OptionableNo Debt/Eq0.00 EPS Q/Q-3.90% Profit Margin- Rel Volume0.92 Prev Close2.81
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume191.86K Price2.89
Recom2.00 SMA2026.59% SMA5021.96% SMA20023.91% Volume176,529 Change2.85%
Dec-01-20 09:00AM  
Nov-23-20 08:30AM  
Oct-27-20 08:00AM  
Oct-25-20 08:30AM  
Sep-14-20 11:43AM  
Sep-08-20 08:00AM  
Aug-13-20 09:00AM  
Jul-28-20 09:00AM  
Jul-20-20 09:00AM  
Jul-10-20 07:25AM  
Jul-06-20 09:00AM  
Jul-02-20 05:00PM  
Jun-01-20 08:30AM  
May-04-20 06:45AM  
Apr-28-20 06:32AM  
Apr-23-20 07:00AM  
Apr-21-20 06:00PM  
Apr-20-20 06:30AM  
Mar-23-20 06:28AM  
Mar-02-20 07:00AM  
Feb-12-20 07:00AM  
Feb-11-20 07:16AM  
Jan-06-20 07:00AM  
Jan-02-20 05:25AM  
Dec-23-19 07:00AM  
Dec-16-19 06:45AM  
Dec-13-19 05:45PM  
Dec-02-19 07:00AM  
Nov-26-19 07:00AM  
Nov-22-19 07:00AM  
Nov-20-19 07:00AM  
Nov-07-19 07:00AM  
Nov-05-19 07:00AM  
Nov-03-19 07:38AM  
Oct-28-19 07:00AM  
Oct-25-19 07:00AM  
Oct-22-19 07:00AM  
Oct-15-19 07:00AM  
Oct-10-19 07:00AM  
Sep-23-19 07:00AM  
Sep-19-19 07:53AM  
Sep-16-19 07:00AM  
Aug-26-19 07:00AM  
Jul-29-19 07:00AM  
Jul-24-19 07:00AM  
Jul-23-19 01:22PM  
Jul-22-19 07:00AM  
Jul-17-19 12:25PM  
Jul-16-19 07:00AM  
May-29-19 07:00AM  
May-24-19 02:56PM  
May-21-19 07:00AM  
May-13-19 07:00AM  
May-02-19 07:00AM  
Apr-17-19 07:00AM  
Apr-11-19 07:00AM  
Apr-03-19 02:00PM  
Mar-27-19 07:00AM  
Mar-25-19 07:00AM  
Mar-14-19 07:00AM  
Mar-13-19 12:48PM  
Mar-04-19 07:00AM  
Feb-28-19 07:00AM  
Feb-25-19 07:00AM  
Feb-21-19 07:00AM  
Feb-13-19 07:00AM  
Feb-05-19 11:17AM  
Jan-25-19 07:00AM  
Jan-24-19 07:00AM  
Jan-16-19 07:30AM  
Dec-26-18 11:05AM  
Dec-19-18 07:00AM  
Dec-03-18 07:00AM  
Nov-15-18 07:00AM  
Nov-12-18 07:00AM  
Oct-29-18 07:00AM  
Oct-24-18 07:00AM  
Oct-22-18 07:00AM  
Oct-17-18 07:00AM  
Oct-16-18 10:59AM  
Oct-15-18 07:00AM  
Oct-11-18 07:00AM  
Oct-05-18 07:00AM  
Anixa Biosciences, Inc., a biotechnology company, develops diagnostics and therapeutics to diagnose, treat, and prevent cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of cancer, which is based on the body's immune response to the presence of a malignancy. It is also developing a vaccine against triple negative breast cancer; and chimeric endocrine receptor T-cell technology focused on treating ovarian cancer. Anixa Biosciences, Inc. has a collaboration with Urology San Antonio, P.A. and Idaho Urologic Institute, PA for the development of Cchek, a liquid biopsy technology; and with OntoChem GmbH to develop novel Covid-19 therapeutics. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Titterton Lewis H jrDirectorSep 11Buy2.0840,00083,2001,020,326Sep 14 09:29 AM
KUMAR AMITChief Executive OfficerSep 11Buy2.1128,00059,080262,000Sep 11 11:58 AM
Titterton Lewis H jrDirectorJun 16Buy2.2724,50055,615980,326Jun 17 10:30 AM
Titterton Lewis H jrDirectorJun 15Buy2.2731,08370,558955,826Jun 16 11:43 AM
KUMAR AMITChief Executive OfficerJun 12Buy2.0320,00040,600234,000Jun 12 10:48 AM
Titterton Lewis H jrDirectorMar 13Buy2.125,79912,294924,743Mar 17 03:46 PM
KUMAR AMITChief Executive OfficerMar 12Buy1.8220,00036,400214,000Mar 12 10:26 AM
Baskies Arnold MDirectorMar 12Buy1.8410,00018,40041,000Mar 12 01:38 PM
Baskies Arnold MDirectorMar 06Buy2.7110,00027,10031,000Mar 10 02:54 PM
Baskies Arnold MDirectorJan 17Buy3.5310,00035,30021,000Jan 21 11:45 AM
Titterton Lewis H jrDirectorJan 15Buy3.325,00016,600918,944Jan 16 11:22 AM
Titterton Lewis H jrDirectorJan 14Buy3.227,40023,828913,944Jan 15 10:57 AM
KUMAR AMITChief Executive OfficerJan 14Buy2.9920,00059,800194,000Jan 14 10:47 AM